FRANKFURTâ€”German drug maker Bayer AG is in talks to buy Norwegian oncology company Algeta ASA for $2.42 billion, Algeta said Tuesday, as it seeks full control over potential blockbuster cancer treatment Xofigo.

Algeta said Bayer made a bid of 336 Norwegian kroner ($55.11) a share, representing a premium of 27% to the company's closing share price Monday.

"Discussions are at an early stage and further announcements may be...